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Background: Primary Ciliary Dyskinesia (PCD) is a genetically heterogeneous ciliopathy caused by ultrastructural
defects in ciliary or flagellar structure and is characterized by a number of clinical symptoms including recurrent
respiratory infections progressing to permanent lung damage and infertility.
Case presentation: Here we describe our search to delineate the molecular basis in two affected sisters with
clinically diagnosed PCD from a consanguineous Saudi Arabian family, in which all known genes have been
excluded. A homozygosity mapping-based approach was utilized that ultimately identified one single affected-
shared region of homozygosity using 10 additional unaffected family members. A plausible candidate gene was
directly sequenced and analyzed for mutations. A novel homozygous missense aberration (p.Lys1154Gln) was
identified in both sisters in the DNAH1 gene that segregated completely with the disease phenotype. Further
confirmation of this interesting variant was provided by exome-wide analysis in the proband.
Conclusion: Molecular variation in DNAH1 may play a role in PCD and its potential contribution should be
considered in patients where all known genes are excluded.
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Primary ciliary dyskinesia (PCD, CILD, MIM 244400) is
a clinically and genetically heterogeneous disorder of
motile cilia dysfunction typically caused by an autosomal
recessive mode of inheritance. PCD is characterized by
various clinical manifestations, including chronic sinus-
itis, otitis media and chronic bronchitis leading to per-
manent lung damage (bronchiectasis). Situs inversus
occurs in approximately 50% of PCD cases, a cohort
who are specifically sub-diagnosed with Kartagener Syn-
drome (KS) based on a triad of symptoms [1]. Clinically,
PCD affected female patients can present with sub-
fertility due to defective oviduct cilia and males can be
infertile due to immotile sperm flagella [2]. Occasionally
hydrocephalus arises from a decrease of cerebrospinal
fluid flow as a consequence of ependymal cilia dysmoti-
lity [3,4]. Previous estimates of the worldwide incidence
of PCD is 1:15,000-1:30,000 live births but these figures
are thought to be underestimated due to under diagnosis* Correspondence: fahmad@kfshrc.edu.sa
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unless otherwise stated.[5] due to such reasons as unfamiliarity with the disease
and non-distinct signs and symptoms [6]. However, this
estimate is reported to be elevated in certain consan-
guineous and isolated populations [7,8]. Clinically, only
half of PCD patients are diagnosed before 5 years of age
and diagnosis is often delayed until adolescence, with
approximately one-third of these patients at adulthood
[6,9,10].
Motile cilia are organelles with a microtubule cytoskel-
eton core, known as the axenome [11] comprising of
nine outer-doublet microtubules, which encircle a cen-
tral microtubule pair (i.e., 9 + 2 pattern). Outer dynein
arms (ODAs) and inner dynein arms (IDAs), which are
attached to the peripheral microtubules, provide the
power by hydrolyzing ATP to the cilia that generate the
force for motility for a number of biological functions
and modulate beat frequency [11]. Dynein arms contain
varying numbers of heavy (responsible for motor activity),
intermediate and light chains [12-15]. Radial spokes and
central pair projections are also present in most motile
cilia and are further structures known to regulate dynein
function [16]. PCD is characterized by ultrastructural de-
fects in the axonemal structure of the 9 + 2 pattern ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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partial loss of inner and/or outer dynein arms, central mi-
crotubular abnormalities and defects of radial spokes.
Thus, such biological defects are demonstrated clinically
by recurrent or chronic sinusitis and bronchiectasis
caused by immotile cilia in the upper and lower airways
and infertility due to impaired oviduct cilia and sperm fla-
gella [16]. To date, mutations in 20 different genes in-
volved in the structure and function of the motile cilia
have been reported to cause PCD, including those that en-
code the dynein axonemal heavy chain (DNAH) proteins
(CILD3 (MIM 608644), caused by mutations in the
DNAH5 gene on chromosome 5p (one of the most com-
mon involved in PCD) and CILD7 (MIM 611884), caused
by mutations in the DNAH11 gene on chromosome 7p21.
Recently, Ben Khelifa and colleagues [17] reported that
homozygous variants in DNAH1 in five unrelated males
were the cause of infertility without any other PCD symp-
toms, a disorder they proposed to call “multiple morpho-




In this study, because of the genetic heterogeneity of PCD,
a homozygosity mapping approach using SNP-microarray
analysis was performed in a Saudi Arabian consanguin-
eous family with two clinically affected sisters. This study
adhered to institutional guidelines (Research Advisory
Council; King Faisal Specialist Hospital & Research
Centre) and to the Helsinki Declaration (http://www.wma.
net/en/30publications/10policies/b3/).
Homozygosity mapping
Genomic DNA from whole blood was isolated from the
affected siblings and 10 additional family members using
the Gentra DNA Extraction Kit (Qiagen, Germantown,
Maryland, USA). Genome-wide genotypes for all individ-
uals were obtained using the Axiom® CEU Human Array
(Affymetrix, Inc., Santa Clara, USA) in accordance with
the manufacturer’s protocol. Homozygosity mapping was
performed using both HomozygosityMapper [18] and
AutoSNPa [19] softwares.
Sanger sequencing
Intronic primers were designed to flank each of the 77
coding exons of the DNAH1 (Genbank accession no.
NM_015512.4) using the Primer3 v.0.4.0 program
(http://bioinfo.ut.ee/primer3-0.4.0/). PCR reactions were
typically performed in a 25 μl reaction volume contain-
ing standard reagents and 20 ng of genomic DNA. Pri-
mer sequences used are available in the supplementary
material (Additional file 1: Table S1). Thermocycling
consisted of an initial denaturation at 95°C for 10 minfollowed by 30 cycles of PCR. Each cycle of PCR consisted
of denaturation at 94°C for 60 s, annealing at 62–68°C for
60 s and extension at 72°C for 60 s. A final extension step
of 10 min at 72°C was added. Sequence analysis was per-
formed using the SeqMan 6.1 module of the Lasergene
(DNA Star Inc. WI, USA) software package and then
compared to the reference GenBank sequence on which
mutation nomenclature was based. Numbering com-
menced with the A of the ATG initiation codon as +1.
Exome sequencing
Commercially available next-generation sequencing Gene
panel version DGD_15112013 (Additional file 2: Table S2)
was performed on the proband. In addition, whole exome
sequencing was also carried out on the proband using the
Illumina® HiSeq2000 platform using TruSeqv3 chemistry
by preparing and enriching the sample according to the
manufacturer’s standard protocol. Concentration of the
each library was determined using Agilent’s (Agilent Tech-
nologies, Santa Clara, CA, USA) QPCR NGS Library
Quantification Kit (G4880A) and the sample was se-
quenced at a final concentration of 10 nM. Mapping and
alignment was performed on read files (Fastq) generated
from the sequencing platform via the manufacturer’s pro-
prietary software and using human genome (hg19/b37)
using the Burrows-Wheeler Aligner (BWA) package, ver-
sion 0.6.1 [20]. Further realignment and variant analysis
were performed eventually determining SNP novelty
against dbSNP (Human Build 135) [21-23]. Variants were
annotated with gene and gene function from Ensembl
(http://www.ensembl.org/index.html) [24] and further
analysis of possible causative variants by filtering the full
exome dataset for all deletions, insertions, nonsense and
canonical splice-site mutations, as well as missense muta-
tions (with a PhyloP score of >3.5 of the underlying base
change) were determined and reported.
Results
Clinical report
The proband had a previous medical history at 13 years
of age with chronic rhinitis, frequent coughing and
wheezing, nasal discharge, and was diagnosed with left
lung bronchitis. She also presented with a multi-nodular
goiter confirmed by fine needle aspiration that revealed
a colloid goiter with cystic degeneration. She was treated
for hypothyroidism and an adenoidectomy was per-
formed. She was referred to King Faisal Specialist Hos-
pital & Research Centre at the age of 29 for IVF for
infertility spanning 5 years. All clinical laboratory tests
were within the normal ranges but a chest X-ray and CT
scan showed the other two classic KS symptoms in com-
bination with infertility; situs inversus (Figure 1A) and
bronchiectasis (Figure 1B). Audiometric evaluation also













Figure 1 Clinical and molecular genetic findings. Panel A) AP Chest X-ray of proband indicating (i) dextrocardia with (ii) right-sided aortic arch.
The gastric air bubble is also in the right side (iii) that is most likely representing situs inversus. Panel B) AP Chest X-ray of proband where arrows
are indicating bronchial wall thickening with mild bronchiectasis in the left middle lobe and also in the right lower lobe. Panel C) Family pedigree
showing the genotypes for the p.Lys1154Gln variation in DNAH1 for all family members that were sequenced. (+) indicates the wild-type allele
and (−) indicates the mutant allele. Arrow indicates the proband. Panel D) Results of analysis of genotyping data with Homozygosity Mapper,
showing 4 ROHs shared among the affected individuals. The ROH on chromosome 3p23-p14.2 containing DNAH1 is indicated by an arrow. Panel
E) Narrowing the single valid ROH by two unaffected family members on chromosome 3 by AutoSNPa analysis. Panel F) Sequence chromatogram
of exon 20 where the mutant arrow points to the site of the c.3460 A > C transversion and Panel G) Multiple protein sequence alignment of
DNAH1 orthologs showing complete conservation of the p.Lys1154 residue compared to the altered residue (indicated by red box).
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proband who was diagnosed with KS at a similar age.
Regions of homozygosity and sanger sequencing
According to Homozygosity Mapper, the proband and her
affected sister shared 4 distinct regions of homozygosity
(ROH) the largest being on chromosome 3p21.31-p21
(Figure 1D). Further analysis using AutoSNPa corrobo-
rated these results for the 4 ROH but three of these were
cancelled out due to unaffected members of the family be-
ing homozygous in the same regions and further narrowed
down the remaining single region (Figure 1E and Figure 2).
This single region, chr3:31,261,252-54,307,163 (hg19 as-
sembly Human Browser Gateway: https://genome.ucsc.
edu/cgi-bin/hgGateway?db=hg19) harbored the DNAH1gene (RefSeq NM_015512.4) encoding the dynein axo-
nemal heavy chain 1 protein that was initially sequenced
in genomic DNA in all 12 family members as a primary
candidate.
Sequence analysis of DNAH1 identified a novel homo-
zygous missense variation in exon 20 (g.52387629A > C;
c.3460 A > C; p.Lys1154Gln) present in both affected sis-
ters (Figure 1F) that completely segregated with the dis-
ease phenotype (Figure 1C). The variant was not found
in 600 ethnically matched normal chromosomes. Protein
sequence alignment of DNAH1 orthologs demonstrated
that the lysine residue is highly conserved across species
(Figure 1G). In addition, p.Lys1154Gln is predicted to be
probably damaging with a score of 0.998 on Polyphen
(http://genetics.bwh.harvard.edu/pph2/index.shtml),
Figure 2 Detailed AutoSNPa homozygosity mapping analysis for all chromosomes in 12 family members. The four shared ROH’s in the
affected sisters are indicated by red boxes, whose coordinates are detailed in the table. The arrows point to the unaffected individuals that cancel
out three of the ROHs on chromosomes 1 and 4. In addition, narrowing of the remaining ROH on chromosome 3 containing DNAH1 is indicated
by red arrows due to shared region present in 2 unaffected siblings (III:3 and III:5).
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Tolerant; http://sift.jcvi.org/www/SIFT_enst_submit.html)
and disease-causing (0.999) using Mutation Taster (http://
www.mutationtaster.org/).
Exome sequencing analysis
There were no causative pathogenic mutations detected
in the genes described in Gene panel version DGD_
15112013. In exome-wide analysis on the proband the p.
Lys1154Gln in DNAH1 was detected as the only possibly
causative variant (Additional file 3: Table S3).
Discussion
In this case report, using a combination of homozygos-
ity mapping and whole exome sequencing method-
ology, we describe the identification of a novel
variation (c.3460 A > C; p.Lys1154Gln) in the DNAH1
gene in PCD affected sisters born from a consanguin-
eous union. In addition to the results described here, a
previous study described that the phenotype of the
DNAH1 mouse homolog MDHC7 knockout resulted in
asthenozoospermia (decrease in the motility of the
spermatozoa) and reduced tracheal ciliary beat fre-
quency using a photo-electrical method [15] and by a
study by Blouin and colleagues who identified a poten-
tial novel PCD locus on chromosome 3p21 [25] bothindicative that aberrations in DNAH1 may cause PCD. Tis-
sue expression studies showed that DNAH1 is heavily
expressed in the testis and trachea, both of which contain
axonemal structures that are altered in PCD patients [26].
The lysine residue altered in these patients is located in the
highly conserved N-terminal stem of the DNAH1 protein.
This component is known to interact with other heavy
chains and additional essential subunits of the axo-
nemal complex [27]. Hence, the substitution of a basic,
strongly positive lysine to a polar uncharged glutamine
residue may alter the 3D confirmation and stability of
the protein structure; disrupt interaction with other
dynein chains and arm subunits and in the function of
this heavy chain with regards to ATP hydrolysis used
in ciliary and flagellar motility. As mentioned previ-
ously [17], variants in DNAH1 have been reported to
cause asthenozoospermia without any accompanying
PCD symptoms. They suggested that DNAH1 function
in ciliated cells is probably compensated by other HC
dyneins, such as DNAH12 (MIM 603340) as it is the
closest paralog. However, the authors noted that none
of the parents of their subjects could be analyzed to
confirm transmission and hence segregation of the
identified variants nor could they exclude the possibility
that some of the variants might be hemizygous with
a deletion on the other allele. Furthermore, they
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to exclude a reduction of ciliary beats that was seen in
the mouse knockout and proposed that future work
would require them to perform thorough physical ana-
lysis of their male subjects to indicate whether their pa-
tients might be at risk of developing late onset PCD. It
is pertinent to note that the patients in this study were
female and all of the subjects in Ben Khalifa and col-
leagues were male, possibly suggesting for now that for
unknown reasons, females may be more sensitive to a
more severe phenotype and/or that the p.Lys1154Gln
variant may have a more severe affect than the variants
identified in the first study. In addition, the authors can-
not exclude the probability that although this variant
was the only one found and may play a role in PCD, it is
possible that a pathogenic causal variant may be located
in an uncharacterized gene or in a known gene that may
have missed by the constraints of the methodology used
in this study. Further investigation including functional
analysis is necessary to determine the effect of this vari-
ant on the protein and to explore the presence of SNPs
or molecular variants working in parallel with the p.
Lys1154Gln variant causing the expanded phenotype
seen in the patient described here. With regards to our
proband, IVF was successful and pre-implantation gen-
etic diagnosis was cancelled as genotyping of the hus-
band indicated that he was wild-type normal
(Figure 1C) and hence all offspring would be obligate
carriers. The pregnancy continued uneventfully until
term and the proband delivered a healthy baby boy by
cesarean section.
Conclusion
In summary, we have identified PCD patients from the
same family with a missense variation that segregates with
the disease phenotype in the DNAH1 gene. In addition to
adding DNAH1 as a gene that may be involved in giving
rise to PCD, the clinical diagnosis and the subsequent gen-
etic findings have translated into an overall positive and
beneficial outcome for the index patient and family and
will be of benefit for future preventative and counseling
measures in the future.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor of this journal.
Additional files
Additional file 1: Table S1. Primers used to amplify the coding exons
of the DNAH1 gene.Additional file 2: Table S2. List of genes that are present on the
Mendelian-inherited disorders (gene panel version DGD_15112013).
Additional file 3: Table S3. A table showing all of the potential
homozygous deleterious variants identified by exome sequencing in the
proband. The variants identified in chromosome 3 are highlighted in
yellow. The p.Lys1154Gln change is highlighted in red and was reported
as the likely variant in the patient after numerous filtering and analysis
criteria had been applied.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
FI: generated and analyzed data and wrote the manuscript. RA and KR:
generated and analyzed data. MAS: Provided all the clinical information, collected
and analyzed data. All authors read and approved the final manuscript.
Acknowledgements
We would like to express our gratitude to the family for their willing
participation. We would also like to extend our appreciation to the
Sequencing and Genomics Core Facilities at KFSH&RC for their technical
support.
Author details
1Department of Genetics, King Faisal Specialist Hospital & Research Centre,
PO Box 3354, Riyadh 11211, Saudi Arabia. 2Department of Medical Genetics,
King Faisal Specialist Hospital & Research Centre, PO Box 3354, Riyadh 11211,
Saudi Arabia.
Received: 8 February 2015 Accepted: 26 February 2015
References
1. Kennedy MP, Omran H, Leigh MW, Dell S, Morgan L, Molina PL, et al.
Congenital heart disease and other heterotaxic defects in a large cohort of
patients with primary ciliary dyskinesia. Circulation. 2007;115(22):2814–21.
2. Zariwala MA, Omran H, Ferkol TW. The emerging genetics of primary ciliary
dyskinesia. Proc Am Thorac Soc. 2011;8(5):430–3.
3. Ibanez-Tallon I, Gorokhova S, Heintz N. Loss of function of axonemal dynein
Mdnah5 causes primary ciliary dyskinesia and hydrocephalus. Hum Mol
Genet. 2002;11(6):715–21.
4. Kosaki K, Ikeda K, Miyakoshi K, Ueno M, Kosaki R, Takahashi D, et al. Absent
inner dynein arms in a fetus with familial hydrocephalus-situs abnormality.
Am J Med Genet A. 2004;129A(3):308–11.
5. Rott HD. The Kartagener syndrome and the syndrome of immotile cilia.
ZFA: Zeitschrift fur Allgemeinmedizin. 1980;56(6):382–6.
6. Boon M, Jorissen M, Proesmans M, De Boeck K. Primary ciliary dyskinesia, an
orphan disease. Eur J Pediatr. 2013;172(2):151–62.
7. Castleman VH, Romio L, Chodhari R, Hirst RA, de Castro SC, Parker KA, et al.
Mutations in radial spoke head protein genes RSPH9 and RSPH4A cause
primary ciliary dyskinesia with central-microtubular-pair abnormalities.
Am J Hum Genet. 2009;84(2):197–209.
8. Jeganathan D, Chodhari R, Meeks M, Faeroe O, Smyth D, Nielsen K, et al.
Loci for primary ciliary dyskinesia map to chromosome 16p12.1-12.2 and
15q13.1-15.1 in Faroe islands and Israeli Druze genetic isolates. J Med
Genet. 2004;41(3):233–40.
9. Coren ME, Meeks M, Morrison I, Buchdahl RM, Bush A. Primary ciliary
dyskinesia: age at diagnosis and symptom history. Acta Paediatr.
2002;91(6):667–9.
10. Kuehni CE, Frischer T, Strippoli MP, Maurer E, Bush A, Nielsen KG, et al.
Factors influencing age at diagnosis of primary ciliary dyskinesia in
European children. Eur Respir J. 2010;36(6):1248–58.
11. Satir P, Christensen ST. Overview of structure and function of mammalian
cilia. Annu Rev Physiol. 2007;69:377–400.
12. Asai DJ. Multi-dynein hypothesis. Cell Motil Cytoskeleton. 1995;32(2):129–32.
13. Gibbons BH, Asai DJ, Tang WJ, Hays TS, Gibbons IR. Phylogeny and
expression of axonemal and cytoplasmic dynein genes in sea urchins.
Mol Biol Cell. 1994;5(1):57–70.
14. Gibbons IR, Gibbons BH, Mocz G, Asai DJ. Multiple nucleotide-binding sites
in the sequence of dynein beta heavy chain. Nature. 1991;352(6336):640–3.
Imtiaz et al. BMC Medical Genetics  (2015) 16:14 Page 6 of 615. Neesen J, Kirschner R, Ochs M, Schmiedl A, Habermann B, Mueller C, et al.
Disruption of an inner arm dynein heavy chain gene results in
asthenozoospermia and reduced ciliary beat frequency. Hum Mol Genet.
2001;10(11):1117–28.
16. Mazor M, Alkrinawi S, Chalifa-Caspi V, Manor E, Sheffield VC, Aviram M, et al.
Primary ciliary dyskinesia caused by homozygous mutation in DNAL1,
encoding dynein light chain 1. Am J Hum Genet. 2011;88(5):599–607.
17. Ben Khelifa M, Coutton C, Zouari R, Karaouzene T, Rendu J, Bidart M, et al.
Mutations in DNAH1, which encodes an inner Arm heavy chain dynein, lead
to male infertility from multiple morphological abnormalities of the sperm
flagella. Am J Hum Genet. 2014;94(1):95–104.
18. Seelow D, Schuelke M, Hildebrandt F, Nurnberg P. HomozygosityMapper–an
interactive approach to homozygosity mapping. Nucleic Acids Res (Web
Server Issue). 2009;37:W593–9.
19. Carr IM, Flintoff KJ, Taylor GR, Markham AF, Bonthron DT. Interactive visual
analysis of SNP data for rapid autozygosity mapping in consanguineous
families. Hum Mutat. 2006;27(10):1041–6.
20. Li H, Durbin R. Fast and accurate long-read alignment with burrows-
wheeler transform. Bioinformatics. 2010;26(5):589–95.
21. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al.
The genome analysis toolkit: a MapReduce framework for analyzing next-
generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.
22. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The
sequence alignment/Map format and SAMtools. Bioinformatics.
2009;25(16):2078–9.
23. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A
framework for variation discovery and genotyping using next-generation
DNA sequencing data. Nat Genet. 2011;43(5):491–8.
24. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, et al. The
ensembl genome database project. Nucleic Acids Res. 2002;30(1):38–41.
25. Blouin JL, Meeks M, Radhakrishna U, Sainsbury A, Gehring C, Sail GD, et al.
Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive
locus heterogeneity. Eur J Hum Genet. 2000;8(2):109–18.
26. Chapelin C, Duriez B, Magnino F, Goossens M, Escudier E, Amselem S.
Isolation of several human axonemal dynein heavy chain genes: genomic
structure of the catalytic site, phylogenetic analysis and chromosomal
assignment. FEBS Lett. 1997;412(2):325–30.
27. King SM. Organization and regulation of the dynein microtubule motor.
Cell Biol Int. 2003;27(3):213–5.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
